Sign up for email alerts of latest news, events, new funding opportunities and more.
Showing all Leadership Success Stories
26 Feb 2019
Professor Patrick Chinnery has been appointed as MRC Clinical Director. He joins the senior management team and will play a key role in developing, promoting and implementing MRC research programmes, working with national and international partners.
3 Oct 2018
The MRC is delighted to congratulate Professor Sir Gregory Winter, a former deputy director of the MRC Laboratory of Molecular Biology, Cambridge, on being awarded the Nobel Prize in Chemistry jointly with Frances H. Arnold and George P. Smith.
27 Sep 2018
Adaptive clinical trials are transforming the efficiency of drug development and the MRC has played a crucial role in implementing this innovative method into the UK clinical trials landscape. This trial methodology helps to deliver the right treatment to the right patient faster than ever before.
11 Jun 2018
Dr Richard Henderson, Molecular Biologist and Biophysicist at the MRC Laboratory of Molecular Biology was made a Companion of Honour in the 2018 Queen’s Birthday Honours for services to electron microscopy of biological molecules.
18 May 2018
Population health experts met to share their progress on health inequality during an MRC-funded symposium at the first World Congress on Migration, Ethnicity, Race and Health in Edinburgh on 17 May.
14 May 2018
MRC-supported researchers are among the 62 scientists elected as new EMBO Members.
10 May 2018
MRC-supported scientists are among the 48 distinguished medical researchers elected as Fellows of the Academy of Medical Sciences.
9 May 2018
MRC-supported researchers are among the 60 eminent scientists elected as Fellows of the Royal Society.
4 Apr 2018
On 1 April, leading immunologist Professor Paul Kaye started his tenure as the new Chair of the MRC Infections and Immunity Board.
3 Apr 2018
The UKRI Future Leaders Fellowship scheme (FLF), aims to develop, retain, attract and sustain research and innovation talent in the UK. Providing up to seven years of funding, for at least 550 early-career researchers and innovators, the scheme will tackle difficult and novel challenges.